Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Malick Bah, Alhassane Ismael Toure, Mamadou Bobo Souare, Kalil Cisse, Ibrahima Kalil Conde, Bangaly Traore
Introduction : Breast cancer is the most common and deadly cancer among women worldwide. Immunohistochemistry techniques are routinely used to assess hormone receptor (HR) expression and the HER2 oncogene in breast cancer. The objective of this study was to d…
Freddy Houéhanou Rodrigue Gnangnon, Marie-Christel Laleye, Dieudonné Vodounnon, Yacoubou Imorou Souaibou, Dansou Gaspard Gbessi, Francis Moise Dossou, 1 1
Background: Digestive cancers are a major contributor to global cancer-related morbidity and mortality. With an estimated 19 million new cases and 9 million deaths annually, cancer now exceeds HIV/AIDS, tuberculosis, and malaria as a cause of death worldwide.…
Freddy Houéhanou Rodrigue Gnangnon, Ismail Lawani, Antoine Azon, René Hounsou, Roland Goudou, Sètondji Gilles Roger Attolou, Dansou Gaspard Gbessi, 1 1, 1 1
Background: Gastric cancer remains a major public health challenge in low- and middle-income countries, where late-stage diagnosis and limited access to specialized surgical oncology care adversely affect outcomes. Surgery remains the cornerstone of curative…
Percy Guzmán, Michael T. Halpern
Introduction : Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Understanding the influence of patient characteristics and treatment modalities on delays in care and related outcomes is crucial for optimizing treatment strategies…
Percy Guzman, Karol Castillo, Marvin Yglesias, Andrea Alfaro, Giovanna Mainieri, Emmanuel Castillo, Alexander Leon
Objective : To evaluate the impact of tumor location, TNM stage, and treatment modalities on survival among colorectal cancer (CRC) patients in Costa Rica (CR). Design : Retrospective cohort study. Setting : Centro de Detección Temprana de Cáncer Gástrico (CD…
Jin Yu, Hong Zhu, Jordan K. Rice, Mark S. Kindy, 1 1, 1 1
Glioblastoma multiforme (GBM) is the deadliest brain tumor and is one of a group of tumors referred to as gliomas. GBMs make up approximately 15% of all primary brain tumors. Even with the standard therapies of surgical resection with radiation and chemothera…
Chaymae Chbihi, Hafssa El Hilali, Samia El Hakym, Diango Keita, Sara Nejjari, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas, 1 1
Introduction: Palbociclib, a CDK4/6 inhibitor, has significantly improved outcomes in patients with HR+/HER2− metastatic breast cancer. While its efficacy has been demonstrated in randomized clinical trials, real-world comparative data between first-line (1L)…
Mir Sadat-Ali, Haifa A. Al-Turki, Mohammed Ghouse Mohiuddin, Surendra Bathula, 1 1
Since long surgical excision of the tumors, followed by anti-cancer therapy, and irradiation were the basic tenets of management of all malignancies. Recently, Dendritic Cells (DCs) therapy has appeared on the horizon as a sparkling star in the management of…
Abir Oufrid, Basma Aabboub, Diango Keita, Sara Nejjari, Samia El Hakym, Hafssa El Hilali, Chaymae Chbihi, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas
Background: Hepatocellular carcinoma (HCC) usually develops in the setting of cirrhosis or chronic liver disease. Its occurrence in a non-cirrhotic liver and in the absence of viral hepatitis is rare and represents a diagnostic challenge due to the lack of ri…
Hafssa El Hilali, Samia El Hakym, Chaymae Chbihi, Sara Nejjari, Diango Keita, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas, 1 1
Intr oduction: Triple-negative breast cancer (TNBC) has a poor prognosis with a high relapse rate. This study aims to identify predictors of relapse in a Moroccan cohort. Methods: A retrospective study including 130 patients treated between 2016 and 2021. Ana…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).